Subclinical perfusion deficits in patients with

Objectives
To assess the degree of cardiac microvascular dysfunction in individuals type 2 diabetes (T2D) without coronary disease or hypertension, compared to healthy, nondiabetic controls.
Methods
This cross sectional pilot data included 2 groups of subjects: Patients diagnosed with type 2 diabetes (Hb A1c 7.5-9.9%; mean age 59.3±7.17; n=6), and healthy, non-diabetic age-matched controls (mean age 51.9±10.3; n=10). Medical history and ECG were reviewed to rule out ischemic heart disease. Qualified patients underwent a CMR-Adenosine stress perfusion,
Results
Subendocardial perfusion delays were observed in 4 out of 6 diabetic patients, and 0 of 10 healthy controls (p < 0.05).
Importantly, the T2D patients exhibited primarily diffuse or circumferential perfusion deficits (Figure 1 ). Controls were normotensive (125.3/79.7 mmHg ± 6.1/2.8 mmHg), and patients had controlled blood pressure (mean 132.2/ 79.8 mmHg ± 8.5/5.2 mmHg), primarily through ACE inhibitors. Patients and controls had normal systolic function (LV EF 57.7 ± 3.01 and 57.8 ± 5.4, respectively).
Conclusion
The observed perfusion abnormality supports previous nuclear imaging findings and pathophysiological research of diabetic heart disease and may indicate more diffuse patterns of microvascular disease. Further studies 1
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